Search Result

Results for "

amylin receptors

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Amylin Receptor (12) CGRP Receptor (5) GCGR (1) Insulin Receptor (1)
By Research Areas:	Cancer (2) Endocrinology (2) Metabolic Disease (11) Neurological Disease (1)

Inhibitors & Agonists

Peptides

Isotope-Labeled Compounds

Targets Recommended: Amylin Receptor

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P11245A

NN1213 acetate	Amylin Receptor	Metabolic Disease
NN1213 acetate (Peptide 21), a long-acting human amylin peptide analog, is a selective **Amylin receptor agonist with an EC₅₀** of 0.177 and 0.262 nM for hAMY3R and rAMY3R, respectively. NN1213 acetate significantly reduces appetite in rat and dog models. NN1213 acetate can be used for antiobesity research .

HY-P0090S

Calcitonin-13C6,15N4 (salmon) TFA Salmon calcitonin-¹³C₆,¹⁵N₄ TFA	CGRP Receptor	Metabolic Disease
Calcitonin- ¹³C₆, ¹⁵N₄ (salmon) (Salmon calcitonin- ¹³C₆, ¹⁵N₄) TFA is ¹³C and ¹⁵N-labeled Calcitonin (salmon) (HY-P0090). Calcitonin (salmon) , a calcium regulating hormone, is a dual-action amylin and calcitonin receptor agonist, could stimulate bone formation and inhibit bone resorption .

HY-P1473

Amylin (8-37), rat amylin (8-37) (mouse, rat)	Amylin Receptor	Metabolic Disease
Amylin (8-37), rat is a truncated analog of native Amylin that selectively inhibits insulin-related glucose uptake and glycogen deposition in muscle tissue. Amylin (8-37), rat is a weak **amylin receptor (AMY**) antagonist.

HY-P1464

Amylin, amide, rat amylin (rat)	Amylin Receptor	Metabolic Disease
Amylin, amide, rat is a potent and high affinity ligand of Amylin receptor AMY1 and AMY3 receptors and variably of AMY2 receptors; binding studies are generally used for the latter receptor.

HY-P1393

AC 187	Amylin Receptor	Endocrinology
AC 187 is a potent and orally active **amylin receptor antagonist with an IC₅₀ of 0.48 nM and a K_i** of 0.275 nM. AC 187 shows more selective for amylin receptor than calcitonin and CGRP receptors. AC 187 has neuroprotective effects .

HY-P1393A

AC 187 TFA	Amylin Receptor	Endocrinology
AC 187 TFA is a potent and orally active **amylin receptor antagonist with an IC₅₀ of 0.48 nM and a K_i** of 0.275 nM. AC 187 TFA shows more selective for amylin receptor than calcitonin and CGRP receptors. AC 187 TFA has neuroprotective effects .

HY-P1782

Calcitonin (8-32), salmon	Amylin Receptor	Metabolic Disease
Calcitonin (8-32), salmon is a highly selective **amylin receptor** antagonist .

HY-P11274A

Zenagamtide sodium Amycretin sodium; NN 9487 sodium	Amylin Receptor Insulin Receptor	Metabolic Disease
Zenagamtide is a glucagon-like peptide (GLP-1) and **amylin receptors** agonist .

HY-P11245

NN1213	Amylin Receptor	Metabolic Disease
NN1213 (Peptide 21), a long-acting human amylin peptide analog, is a selective **Amylin receptor agonist with an EC₅₀** of 0.177 and 0.262 nM for hAMY3R and rAMY3R, respectively. NN1213 significantly reduces appetite in rat and dog models. NN1213 can be used for antiobesity research .

HY-P11274

Zenagamtide Amycretin; NN 9487	GCGR Amylin Receptor	Metabolic Disease
Zenagamtide is a glucagon-like peptide (GLP-1) and **amylin receptors** agonist .

HY-P3462

Cagrilintide 3 Publications Verification	CGRP Receptor	Metabolic Disease
Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and *calcitonin G protein-coupled receptor* (CTR)** agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity .

HY-P11269

Lenbelintide	Amylin Receptor	Metabolic Disease
Lenbelintide is a dual *amylin/calcitonin* receptor agonist. Lenbelintide can be studied in research on obesity .

HY-P11320

Davalintide	Amylin Receptor CGRP Receptor	Metabolic Disease
Davalintide is an Amylin (HY-P1464)-mimetic peptide with greater potency and longer-lasting effects. Davalintide is a potent agonist of **amylin receptor (IC₅₀** = 0.04 nM), calcitonin receptor (IC₅₀ = 0.06 nM) and calcitonin related peptide receptor (CGRP receptor) (IC₅₀ = 3.1 nM). Davalintide shows stronger potency to Amylin to activate cyclic AMP production through the calcitonin receptor (EC₅₀ = 1.4 nM). Davalintide regulates blood sugar and weight through various mechanisms such as delaying gastric emptying, inhibiting glucagon secretion, and reducing food intake. Davalintide can be used for the studies of anti-obesity and anti-diabetes .

HY-P0090

Calcitonin (salmon) 1 Publications Verification Salmon calcitonin	CGRP Receptor	Cancer
Calcitonin salmon, a calcium regulating hormone, is a dual-action *amylin* and calcitonin receptor agonist, could stimulate bone formation and inhibit bone resorption.

HY-P0090A

Calcitonin (salmon) (acetate) Salmon calcitonin acetate	CGRP Receptor	Cancer
Calcitonin (salmon) (acetate) is a dual-action *amylin* and calcitonin receptor agonist, can stimulate bone formation and inhibit bone resorption .The acetate form can affect the absorption and efficacy of hormones .

HY-P10235

Cyclic AC253	Amylin Receptor	Neurological Disease
Cyclic AC253 is an antagonist for **amylin receptor, with IC₅₀** of 0.3 μM. Cyclic AC253 exhibits neuroprotective efficacy against Aβ toxicity and abrogates Aβ-induced impairment of hippocampal long-term potentiation. Cyclic AC253 penetrate blood-brain barrier (BBB) .

Cat. No.	Product Name	Target	Research Area

HY-P11245A

NN1213 acetate	Amylin Receptor	Metabolic Disease
NN1213 acetate (Peptide 21), a long-acting human amylin peptide analog, is a selective **Amylin receptor agonist with an EC₅₀** of 0.177 and 0.262 nM for hAMY3R and rAMY3R, respectively. NN1213 acetate significantly reduces appetite in rat and dog models. NN1213 acetate can be used for antiobesity research .

HY-P0090S

Calcitonin-13C6,15N4 (salmon) TFA Salmon calcitonin-¹³C₆,¹⁵N₄ TFA	CGRP Receptor	Metabolic Disease
Calcitonin- ¹³C₆, ¹⁵N₄ (salmon) (Salmon calcitonin- ¹³C₆, ¹⁵N₄) TFA is ¹³C and ¹⁵N-labeled Calcitonin (salmon) (HY-P0090). Calcitonin (salmon) , a calcium regulating hormone, is a dual-action amylin and calcitonin receptor agonist, could stimulate bone formation and inhibit bone resorption .

HY-P1473

Amylin (8-37), rat amylin (8-37) (mouse, rat)	Amylin Receptor	Metabolic Disease
Amylin (8-37), rat is a truncated analog of native Amylin that selectively inhibits insulin-related glucose uptake and glycogen deposition in muscle tissue. Amylin (8-37), rat is a weak **amylin receptor (AMY**) antagonist.

HY-P1464

Amylin, amide, rat amylin (rat)	Amylin Receptor	Metabolic Disease
Amylin, amide, rat is a potent and high affinity ligand of Amylin receptor AMY1 and AMY3 receptors and variably of AMY2 receptors; binding studies are generally used for the latter receptor.

HY-P1393

AC 187	Amylin Receptor	Endocrinology
AC 187 is a potent and orally active **amylin receptor antagonist with an IC₅₀ of 0.48 nM and a K_i** of 0.275 nM. AC 187 shows more selective for amylin receptor than calcitonin and CGRP receptors. AC 187 has neuroprotective effects .

HY-P1393A

AC 187 TFA	Amylin Receptor	Endocrinology
AC 187 TFA is a potent and orally active **amylin receptor antagonist with an IC₅₀ of 0.48 nM and a K_i** of 0.275 nM. AC 187 TFA shows more selective for amylin receptor than calcitonin and CGRP receptors. AC 187 TFA has neuroprotective effects .

HY-P1782

Calcitonin (8-32), salmon	Amylin Receptor	Metabolic Disease
Calcitonin (8-32), salmon is a highly selective **amylin receptor** antagonist .

HY-P11274A

Zenagamtide sodium Amycretin sodium; NN 9487 sodium	Amylin Receptor Insulin Receptor	Metabolic Disease
Zenagamtide is a glucagon-like peptide (GLP-1) and **amylin receptors** agonist .

HY-P11245

NN1213	Amylin Receptor	Metabolic Disease
NN1213 (Peptide 21), a long-acting human amylin peptide analog, is a selective **Amylin receptor agonist with an EC₅₀** of 0.177 and 0.262 nM for hAMY3R and rAMY3R, respectively. NN1213 significantly reduces appetite in rat and dog models. NN1213 can be used for antiobesity research .

HY-P11274

Zenagamtide Amycretin; NN 9487	GCGR Amylin Receptor	Metabolic Disease
Zenagamtide is a glucagon-like peptide (GLP-1) and **amylin receptors** agonist .

HY-P3462

Cagrilintide 3 Publications Verification	CGRP Receptor	Metabolic Disease
Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and *calcitonin G protein-coupled receptor* (CTR)** agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity .

HY-P11269

Lenbelintide	Amylin Receptor	Metabolic Disease
Lenbelintide is a dual *amylin/calcitonin* receptor agonist. Lenbelintide can be studied in research on obesity .

HY-P11320

Davalintide	Amylin Receptor CGRP Receptor	Metabolic Disease
Davalintide is an Amylin (HY-P1464)-mimetic peptide with greater potency and longer-lasting effects. Davalintide is a potent agonist of **amylin receptor (IC₅₀** = 0.04 nM), calcitonin receptor (IC₅₀ = 0.06 nM) and calcitonin related peptide receptor (CGRP receptor) (IC₅₀ = 3.1 nM). Davalintide shows stronger potency to Amylin to activate cyclic AMP production through the calcitonin receptor (EC₅₀ = 1.4 nM). Davalintide regulates blood sugar and weight through various mechanisms such as delaying gastric emptying, inhibiting glucagon secretion, and reducing food intake. Davalintide can be used for the studies of anti-obesity and anti-diabetes .

HY-P0090

Calcitonin (salmon) 1 Publications Verification Salmon calcitonin	CGRP Receptor	Cancer
Calcitonin salmon, a calcium regulating hormone, is a dual-action *amylin* and calcitonin receptor agonist, could stimulate bone formation and inhibit bone resorption.

HY-P0090A

Calcitonin (salmon) (acetate) Salmon calcitonin acetate	CGRP Receptor	Cancer
Calcitonin (salmon) (acetate) is a dual-action *amylin* and calcitonin receptor agonist, can stimulate bone formation and inhibit bone resorption .The acetate form can affect the absorption and efficacy of hormones .

HY-P10235

Cyclic AC253	Amylin Receptor	Neurological Disease
Cyclic AC253 is an antagonist for **amylin receptor, with IC₅₀** of 0.3 μM. Cyclic AC253 exhibits neuroprotective efficacy against Aβ toxicity and abrogates Aβ-induced impairment of hippocampal long-term potentiation. Cyclic AC253 penetrate blood-brain barrier (BBB) .

Cat. No.	Product Name	Chemical Structure

HY-P0090S

Calcitonin-13C6,15N4 (salmon) TFA
Calcitonin- ¹³C₆, ¹⁵N₄ (salmon) (Salmon calcitonin- ¹³C₆, ¹⁵N₄) TFA is ¹³C and ¹⁵N-labeled Calcitonin (salmon) (HY-P0090). Calcitonin (salmon) , a calcium regulating hormone, is a dual-action amylin and calcitonin receptor agonist, could stimulate bone formation and inhibit bone resorption .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: